Why Is Repligen (RGEN) Up 27.7% Since Last Earnings Report?
Repligen (RGEN) reported Q2 2026 adjusted EPS of 54 cents, beating the consensus estimate of 45 cents, with revenues of $204.1 million up 12% year-over-year. The company raised its full-year 2026 revenue guidance to $813-$835 million and EPS guidance to $2.03-$2.09. Stock has gained 27.7% since the earnings report and received a Zacks Rank #1 (Strong Buy) rating.